Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine

Highly adaptable breast cancer cells that can opportunistically switch between proliferation and quiescence are often responsible for disease relapse. We have developed a function-based selection strategy for such resistant cells, exemplified by SUM149-MA and FC-IBC02-MA triple-negative breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Balraj, Sarli, Vanessa N., Lucci, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021029/
https://www.ncbi.nlm.nih.gov/pubmed/33868584
http://dx.doi.org/10.18632/oncotarget.27922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021029/
https://www.ncbi.nlm.nih.gov/pubmed/33868584
http://dx.doi.org/10.18632/oncotarget.27922

Ejemplares similares